Diagnostic Approach to Myopathy
Initial Clinical Assessment
- The American College of Cardiology recommends beginning with a focused history targeting the pattern of muscle weakness, temporal course, and associated symptoms, followed by creatine kinase (CK) measurement as the primary screening test 1
- Documenting the specific pattern of weakness, distinguishing true weakness from pain or fatigue, and identifying the temporal course are crucial steps in the initial clinical assessment, as recommended by the Mayo Clinic Proceedings 1, 2
- A complete neuromuscular examination, including testing proximal muscle strength and distal strength, is essential for assessing muscle weakness, according to the Gut journal 3, 4, 2
- The European Society of Cardiology suggests examining the skin thoroughly for heliotrope rash, Gottron papules, and other skin findings associated with myositis 1, 2
Initial Laboratory Testing
- Measuring creatine kinase (CK) as the primary marker, along with aldolase, transaminases (AST, ALT), lactate dehydrogenase (LDH), and inflammatory markers, is a critical step in the initial laboratory testing, as recommended by the Praxis Medical Insights: Practical Summaries of Clinical Guidelines 1, 5
- Screening for secondary causes, including hypothyroidism, diabetes, coeliac disease, and electrolyte imbalances, is essential for identifying underlying conditions that may contribute to myopathy, according to the Gut journal 3, 6
Autoantibody Testing
- Requesting myositis-specific antibodies, including anti-Jo-1 and anti-synthetase panel, is crucial for diagnosing inflammatory myopathy, as recommended by the Praxis Medical Insights: Practical Summaries of Clinical Guidelines and the Gut journal 1, 6
- Testing for connective tissue and paraneoplastic antibodies, such as scleroderma antibodies and general autoimmune screen, is essential for identifying associated conditions, according to the Gut journal 3, 6
Advanced Diagnostic Testing
- Proceeding to electromyography (EMG) when diagnosis remains uncertain after initial workup, or to confirm myopathic versus neuropathic process, is a critical step in the diagnostic approach, as recommended by the Praxis Medical Insights: Practical Summaries of Clinical Guidelines 1, 7
- Ordering magnetic resonance imaging (MRI) of proximal muscles with STIR sequences to detect muscle edema and inflammation is essential for identifying muscle involvement, according to the Praxis Medical Insights: Practical Summaries of Clinical Guidelines 7, 1
- Muscle biopsy is the gold standard for definitive diagnosis when inflammatory versus non-inflammatory myopathy cannot be distinguished, as recommended by the Praxis Medical Insights: Practical Summaries of Clinical Guidelines and the Mayo Clinic Proceedings 1, 7, 2
Screening for Complications and Associated Conditions
- Obtaining pulmonary function tests, including CO diffusion capacity, to screen for interstitial lung disease, particularly in patients with anti-synthetase antibodies, is crucial for identifying respiratory complications, according to the Praxis Medical Insights: Practical Summaries of Clinical Guidelines 1
- Checking troponin, ECG, and echocardiogram to exclude cardiac involvement, which can occur in inflammatory myopathies and some muscular dystrophies, is essential for identifying cardiac complications, as recommended by the Praxis Medical Insights: Practical Summaries of Clinical Guidelines 7
- Screening for malignancy in adult patients with dermatomyositis, particularly those with anti-TIF1-γ or anti-NXP2 antibodies, is critical for identifying associated cancers, according to the Praxis Medical Insights: Practical Summaries of Clinical Guidelines 1
Diagnostic Algorithm Based on CK Levels
- If symptomatic with muscle pain/weakness and CK >10 times upper limit of normal, discontinue statins or other potentially offending medications immediately, as recommended by the Journal of the American College of Cardiology 8
- Pursuing inflammatory myopathy workup, including autoantibodies, EMG, MRI, and considering muscle biopsy, is essential for diagnosing inflammatory myopathy, according to the Praxis Medical Insights: Practical Summaries of Clinical Guidelines and the Mayo Clinic Proceedings 1, 2
- Considering immune-mediated necrotizing myopathy if CK remains markedly elevated despite stopping statins is crucial for identifying this condition, as recommended by the Mayo Clinic Proceedings 2